Opinion Article - Research and Reports in Gynecology and Obstetrics (2025) Volume 6, Issue 1

Advancements in urogynecology and contraceptive methods: Integrating women�s pelvic health and reproductive choices

Department of Obstetric Ultrasound, Sechenov University, Russia

*Corresponding Author:

Natui Petri
Department of Obstetric Ultrasound
Sechenov University, Russia
E-mail: natui@petri.ru

Received: 01-Mar-2025, Manuscript No. AARRGO-25-169779; Editor assigned: 03-Mar-2025, PreQC No. AARRGO-25-169779(PQ); Reviewed: 16-Mar-2025, QC No. AARRGO-25-169779; Revised: 22-Mar-2025, Manuscript No. AARRGO-25-169779(R); Published: 28-Mar-2025, DOI:10.35841/aarrgo-6.1.169

Citation: Petri N. Advancements in urogynecology and contraceptive methods: Integrating women’s pelvic health and reproductive choices. Res Rep Gynecol Obstet. 2025;6(1):169

Introduction

Urogynecology, a subspecialty within obstetrics and gynecology, focuses on the diagnosis and treatment of pelvic floor disorders, urinary incontinence, pelvic organ prolapse, and other conditions affecting the urinary and reproductive systems of women. These disorders are common yet often underdiagnosed, significantly impacting quality of life and daily functioning. At the same time, contraceptive methods remain a crucial aspect of women’s healthcare, allowing them to make informed choices about reproduction while preventing unintended pregnancies. The integration of urogynecology and contraceptive counseling is essential, as pelvic floor health and reproductive planning are deeply interlinked in the continuum of women’s health [1].

Advancements in both fields have been driven by innovation in surgical techniques, pharmacological therapies, and patient-centered care models. Minimally invasive procedures in urogynecology have reduced recovery times and improved functional outcomes, while modern contraceptive technologies have expanded options for women, offering better safety, effectiveness, and convenience. This article explores the interplay between urogynecology and contraceptive methods, examining the medical, surgical, and social aspects that influence women’s healthcare decisions.

Urogynecology addresses conditions such as stress urinary incontinence, urge incontinence, overactive bladder, and pelvic organ prolapse. These issues often arise due to pregnancy, childbirth, menopause, obesity, or genetic predisposition. Pelvic floor dysfunction can lead to physical discomfort, social embarrassment, and psychological stress, making early diagnosis and targeted treatment critical. Urogynecologists employ both conservative and surgical approaches, including pelvic floor muscle training, pessary use, mid-urethral slings, and prolapse repair surgeries [2].

The pelvic floor plays a dual role in supporting urinary function and reproductive organs. Pregnancy and vaginal delivery, while natural processes, can stretch or damage pelvic tissues, leading to incontinence or prolapse. Contraceptive planning, particularly postpartum, must consider pelvic floor recovery. For example, women with significant pelvic trauma may prefer contraceptive methods that avoid estrogen, as high estrogen levels can influence tissue healing and vascular supply. Urogynecologists and gynecologists often collaborate to ensure that both pelvic health and family planning needs are met in a coordinated care plan.

Contraceptive methods can be broadly classified into barrier methods (condoms, diaphragms), hormonal methods (oral contraceptives, patches, injectables), intrauterine devices (IUDs), sterilization procedures, and fertility awareness-based methods. Modern contraceptives are evaluated based on their safety profile, reversibility, ease of use, and effectiveness in preventing pregnancy. Urogynecological considerations may arise in women with certain medical conditions—such as recurrent urinary tract infections or pelvic pain—where specific contraceptive devices might be unsuitable [3].

While urogynecology primarily focuses on pelvic health, contraceptive counseling in these patients is critical. Some contraceptive devices, like diaphragms and cervical caps, require placement near pelvic structures affected by prolapse or surgery, making them less ideal for certain patients. Similarly, estrogen-containing contraceptives may pose risks for women with specific urological concerns, such as urinary retention or recurrent infections. Thus, individualized contraceptive selection, guided by both urogynecologic and reproductive needs, ensures optimal outcomes.

Pelvic floor surgeries—such as bladder neck suspensions, sacrocolpopexies, and sling procedures—often necessitate careful timing of contraceptive use. Postoperative healing may be affected by hormonal changes, sexual activity restrictions, and risk of infection. Long-acting reversible contraceptives (LARCs), like hormonal IUDs or subdermal implants, are often preferred for patients undergoing major urogynecologic surgery, as they provide reliable contraception without interfering with surgical recovery or pelvic structures.

The rise of robotic-assisted pelvic floor surgeries has improved precision and patient recovery rates, while 3D ultrasound and MRI imaging have enhanced diagnosis of urogynecologic disorders. In contraception, biodegradable implants, non-hormonal IUDs with advanced copper designs, and smartphone-assisted fertility tracking are reshaping patient choices. Digital health platforms also allow for virtual pelvic floor therapy sessions and contraceptive counseling, increasing accessibility for women in remote or underserved areas [4].

Both urogynecology and contraceptive care require active patient participation. Educating women about the interdependence of pelvic health and reproductive planning empowers them to make informed decisions. Shared decision-making involves discussing all available treatment and contraceptive options, weighing risks and benefits, and aligning medical recommendations with the patient’s personal values and lifestyle. This approach has been shown to improve adherence to pelvic floor therapy and contraceptive regimens.

Pelvic floor disorders and unintended pregnancies are public health concerns that can have significant socioeconomic impacts. Addressing these through integrated care in urogynecology and contraception can reduce healthcare costs, prevent complications, and improve overall quality of life for women. Policies that ensure access to specialized urogynecologic care, affordable contraceptive options, and comprehensive reproductive education are essential for achieving broader health equity [5].

Conclusion

Urogynecology and contraceptive methods, though distinct areas of women’s health, are closely connected through the shared goal of improving quality of life, autonomy, and long-term well-being. Advances in minimally invasive urogynecologic surgery, personalized contraceptive technologies, and patient-centered care models are reshaping the way women experience pelvic and reproductive health. By fostering interdisciplinary collaboration between urogynecologists, gynecologists, and reproductive health specialists, healthcare systems can ensure that women receive integrated, evidence-based care tailored to their unique needs. As the fields continue to evolve, the emphasis must remain on education, accessibility, and individualized treatment to empower women in managing both their pelvic health and reproductive choices.

References

1. Ferreira LB, Lobo CV, Miranda AE, et al. Dietary patterns during pregnancy and gestational weight gain: A systematic review. Rev Bras de Ginecol e Obstet. 2022;44:540-7.

Indexed at, Google Scholar, Crossref

2. Ayers BL, Bogulski CA, Bennett-Milburn A, et al. Dietary practices during pregnancy in a Marshallese community: A mixed methods analysis. Int J Environ Res Public Health. 2022;19(11):6360.

Indexed at, Google Scholar, Crossref

3. Huang L, Zhang L, Rao Z, et al. Dietary iodine intake and urinary iodine concentration during pregnancy in Chengdu, China. Asia Pac J Clin Nutr. 2021;30(4):643-50.

Indexed at, Google Scholar, Crossref

4. Ennis M, Lim K, Ball R, et al. Dietary phenylalanine and tyrosine requirements in healthy human pregnancy. Curr Dev Nutr. 2020;4:978.

Indexed at, Google Scholar, Crossref

5. Nacka-Aleksic M, Pirkovic A, Vilotic A, et al. The role of dietary polyphenols in pregnancy and pregnancy-related disorders. Nutrients. 2022;14(24):5246.

Google Scholar,